Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 1.70% | 426.06k | 215.33k |
Vanguard Extended Market Index Fund | 1.10% | 274.61k | 138.79k |
Fidelity Extended Market Index Fund | 0.45% | 111.64k | 56.42k |
iShares Micro Cap ETF | 0.18% | 44.2k | 22.34k |
Fidelity NASDAQ Composite Index Fund | 0.15% | 36.45k | 18.42k |
Fidelity Total Market Index Fund | 0.09% | 22.5k | 11.37k |
Fidelity Series Total Market Index Fund | 0.09% | 21.26k | 10.75k |
Vanguard Institutional Index-Inst Total Stock Market Ind | 0.08% | 19.27k | 9.74k |
Vanguard Balanced Index Fund | 0.02% | 5.06k | 2.56k |
EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 3.41k | 1.72k |
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
06/27 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
06/12 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
05/14 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
04/09 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
03/28 04:05 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
02/06 08:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
12/11 08:30 am
GlobeNewswire Inc.
Read moreDow Jumps Around 200 Points; US Core PCE Inflation Slows In October
11/30 10:42 am
Benzinga
Read moreDow Jumps Over 100 Points; Hormel Foods Earnings Miss Estimates
11/29 03:20 pm
Benzinga
Read moreVivos Therapeutics stock soars as sleep apnea device gets regulatory clearance
11/29 12:09 pm
MarketWatch
Read moreNasdaq Surges Over 100 Points; US Economy Expands Faster Than Expected
11/29 10:48 am
Benzinga
Read moreVivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
11/29 08:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
11/09 05:30 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Closes $4 Million Private Placement
11/02 05:00 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Signs Nationwide Distribution Agreement with Lincare
10/24 07:30 am
GlobeNewswire Inc.
Read moreHere Is Why Bargain Hunters Would Love Fast-paced Mover Vivos Therapeutics, Inc. (VVOS)
10/12 08:50 am
Zacks Investment Research
Read moreVivos Therapeutics to Begin Clinical Trial at Stanford Medicine
10/11 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion
10/05 07:30 am
GlobeNewswire Inc.
Read moreCreating a Profitable Penny Stocks Watchlist
10/05 06:59 am
PennyStocks
Read moreNasdaq Rises 100 Points; RPM International Posts Upbeat Earnings
10/04 02:30 pm
Benzinga
Read moreCrude Oil Falls Sharply; ISM Services PMI Declines In September
10/04 11:59 am
Benzinga
Read moreUS Stocks Rise Following ADP Data; Dow Rises Over 50 Points
10/04 09:44 am
Benzinga
Read moreVivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers
10/04 07:30 am
GlobeNewswire Inc.
Read moreHere's Why Vivos Therapeutics, Inc. (VVOS) Could be Great Choice for a Bottom Fisher
08/23 09:55 am
Zacks Investment Research
Read moreVivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update
08/16 04:05 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call
08/16 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call
08/14 05:06 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call
08/10 08:31 pm
GlobeNewswire Inc.
Read moreNasdaq Down Over 100 Points; US Trade Deficit Shrinks In June
08/08 09:50 am
Benzinga
Read moreWhy ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
07/12 08:19 am
Benzinga
Read moreLooking for a Fast-paced Momentum Stock at a Bargain? Consider Vivos Therapeutics, Inc. (VVOS)
06/13 08:50 am
Zacks Investment Research
Read moreVivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Tops Revenue Estimates
06/08 05:25 pm
Zacks Investment Research
Read moreVivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update
06/08 04:05 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call
06/06 04:30 pm
GlobeNewswire Inc.
Read morePhreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
05/31 05:15 pm
Zacks Investment Research
Read moreGain Therapeutics, Inc. (GANX) Reports Q1 Loss, Tops Revenue Estimates
05/12 09:15 am
Zacks Investment Research
Read more